A Phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Hormone therapy is very effective for treating prostate cancer however it produces a number of side effects including muscle and bone loss, fat gain, and increased risk of death from heart disease and diabetes. In other populations physical exercise has proven particulary effective for preventing such problems however no long term studies with prostate cancer patients have ever confirmed this. Knowledge gained from this study has potential to markedly reduce suffering and increase survival.

Funded Activity Details

Start Date: 01-01-2009

End Date: 01-01-2012

Funding Scheme: NHMRC Project Grants

Funding Amount: $519,330.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Oncology And Carcinogenesis

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cardiovascular disease | clinical practice guidelines | exercise and bone strength | exercise physiology | exercise testing and rehabilitation | fall risk factors | obesity | osteoporosis | prostate cancer | type 2 diabetes